Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PFIZER's THREE-PRONGED OTC GROWTH STRATEGY

This article was originally published in The Tan Sheet

Executive Summary

PFIZER's THREE-PRONGED OTC GROWTH STRATEGY includes capitalizing on current brands through line extensions, acquisitions and Rx-to-OTC switches, Exec VP and Chief Financial Officer Hank McKinnell told a meeting of securities analysts Feb. 8 in New York City. "The foundation for future growth is being laid," McKinnell said, "with the initiation of a number of complementary strategies," such as "looking to further capitalize on the strong brand identification of leading products in their category," including Desitin and Unisom.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082465

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel